S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 7, 2012
April 24, 2020
bdcb4e58-2f39-40e7-90c5-9f222d9203c1
Related Documents
S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
Guidance DocumentMarch 8, 2010Center for Drug Evaluation and Research
S6(R1) Addendum: Preclinical Safety Evaluation of Biotechnology: Guidance for Industry
Guidance DocumentDecember 17, 2009Center for Drug Evaluation and Research
Q11 Development and Manufacture of Drug Substances
Guidance DocumentNovember 20, 2012Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.